Lamivudine and famciclovir combination therapy with or without addition of IFN-alfa-2b for HBeAg positive chronic hepatitis B

被引:0
|
作者
Sangfelt, BP
Uhnoo, I
Hollander, A
Lindh, G
Weiland, O
机构
[1] Karolinska Inst, Stockholm, Sweden
[2] Univ Uppsala Hosp, Uppsala, Sweden
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1867
引用
收藏
页码:630A / 630A
页数:1
相关论文
共 50 条
  • [1] Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: A pilot study
    Sangfelt, P
    Uhnoo, I
    Hollander, A
    Lindh, G
    Weiland, O
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (07) : 505 - 511
  • [2] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [3] Combination Therapy With Lamivudine and Famciclovir for Chronic Hepatitis B Infection
    Shen, Hong
    Alsatie, Mazen
    Eckert, George
    Chalasani, Naga
    Lumeng, Lawrence
    Kwo, Paul Y.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (04) : 330 - 336
  • [4] Combination therapy of hepatitis B with lamivudine and famciclovir
    Purow, JM
    Weisz, K
    Eison, RC
    Talal, A
    Dieterich, DT
    GASTROENTEROLOGY, 1999, 116 (04) : A800 - A800
  • [6] Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
    Janssen, HLA
    van Zonneveld, M
    Senturk, H
    Zeuzem, S
    Akarca, US
    Cakaloglu, Y
    Simon, C
    So, TMJ
    Gerken, G
    de Man, RA
    Niesters, HGM
    Zondervan, P
    Hansen, B
    Schalm, SW
    LANCET, 2005, 365 (9454): : 123 - 129
  • [7] Combination therapy of E-antigen-negative/virus-DNA-positive (precore mutant) chronic hepatitis B with Famciclovir or Lamivudine and interferon (IFN) alfa-2A
    Schiefke, I
    Oesen, U
    Etzrodt, G
    Wiedmann, M
    Liebert, UG
    Moessner, J
    Berr, F
    JOURNAL OF HEPATOLOGY, 2000, 32 : 200 - 200
  • [8] Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B
    Vassiliadis, Themistoklis
    Tziomalos, Konstantinos
    Patsiaoura, Kalliopi
    Zagris, Thomas
    Giouleme, Olga
    Soufleris, Konstantinos
    Grammatikos, Nikolaos
    Theodoropoulos, Konstantinos
    Mpoumponaris, Alexandros
    Dona, Konstantina
    Zezos, Petros
    Nikolaidis, Nikolaos
    Orfanou-Koumerkeridou, Eleni
    Balaska, Aikaterini
    Eugenidis, Nikolaos
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (10) : 1582 - 1588
  • [9] Peginterferon alfa-2b alone or in combination with lamivudine for chronic HBeAg-positive hepatitis B: a randomized controlled trial.
    Janssen, HLA
    van Zonneveld, M
    Senturk, H
    Zeuzem, S
    Akarca, U
    Cakaloglu, Y
    Simon, K
    Kit, TSM
    Gerken, G
    de Man, RA
    Niesters, HGM
    Schalm, SW
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A11 - A11
  • [10] Viral Hepatitis ( plus Antiviral Therapy) Combination therapy of lamivudine and adefovir in patients of HBeAg positive chronic hepatitis B
    Dayal, Vishwamohan
    Kumar, A.
    Jha, S. K.
    Sharan, A.
    Kumar, U.
    Shahi, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 419 - 419